During the last RESI (Redefining Early Stage Investments) Conference – the event series organized by Life Science Nation, a Venture Valuation long-time partner – Dr. Patrik Fried delivered a session on life science deal and product valuations. The notes from the workshop are available to download here
Venture Valuation CEO, Dr. Patrik Frei is one of the experts working as mentors for MassChallengeCH, a famous startup accelerator. He helps new entrepreneurs understand the concepts and meaning of company valuation. Below, you can find a link to the notes from his workshop about assessing a company prior to valuation. Assessing the Valuation of New … Continue reading Assessing the Valuation of New Ventures – MassChallengeCH, Lausanne, September 2017
Last month, CEO of Venture Valuation, Dr Patrik Frei, delivered a live webinar titled ‘Valuation of Life Sciences Start-up’ to healthcare alumni of Harvard Business School You can watch the webinar here. Due to a large number of questions from participants, not all of them could be answered during the event. In this post, we … Continue reading Valuation of Life Sciences Start-up – Questions and Answers
On 7th of June 2017, CEO of Venture Valuation, Dr Patrik Frei, delivered a live webinar titled ‘Valuation of Life Sciences Start-up’ to healthcare alumni of Harvard Business School. The online event was a part of Healthcare Roundtable, a series of interactive presentations by industry leaders organised by HBS Healthcare Alumni Association. Dr. Frei talked about the significance … Continue reading Dr. Patrik Frei Delivers a Webinar to Harvard Business School Alumni
Dr. Patrik Frei, Venture Valuation CEO and a worldwide known expert in life sciences company and product valuation, delivered a workshop on the topic during he Redefining Early Stage Investments Conference in San Diego. The notes from the workshop are available to download here.
The topic if this year’s evening event at JPM in San Francisco co-organized by BaselArea.swiss Economic Promotion, KPMG and Venture Valuation was Designing The Future in Life Sciences – A Discussion About (Human) Capital & Innovation. How will life sciences look like in – let’s say – 2030? What are sustainable and future business models for biotech … Continue reading Panel at JPM January 2017 – Future of Life Sciences
RESI Conference, San Francisco January 2017, 23 pages Valuation and HealthTech in Asia, RESI (Jan 2017)
Venture Valuations Dr. Aitana Peire and Dr. Patrik Frei have published an article “What is the value of a deal?” in Nature Publishing Groups’ biopharmadealmakers.nature.com. The article is available online as well as in the biopharmadealmakers supplement June 2016 edition of nature biotechnology and Nature Reviews Drug Discovery. The pharmaceutical and biotechnology industries see over … Continue reading What is the value of a deal?
